KrishnaV.KomanduriMD
Hematology • San Francisco, CAHematologic Oncology
Julius R. Krevans, MD Distinguished Professor of Medicine; Chief, UCSF Health Division of Hematology/Oncology; Physician-in-Chief, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Dr. Komanduri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
Ste 3039
San Francisco, CA 94143Phone+1 415-476-1000Fax+1 305-243-6361
Summary
- Dr. Krishna Komanduri is an academic hematologist and medical oncologist who specializes in hematopoietic transplantation and cellular therapy. He received his medical degree from University of Minnesota Medical School and has been in practice 26 years. He has laboratory expertise in translational immunology, and has expertise in health care delivery, value and access to therapies.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1994 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Minnesota Medical SchoolClass of 1991
Certifications & Licensure
CA State Medical License 2023 - 2025
FL State Medical License 2008 - 2025
TX State Medical License 2003 - 2012- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- President American Society for Transplantation and Cellular Therapy, 2017-2018
- Chair, Advisory Group on Financial Barriers to Transplantation National Marrow Donor Program
- Co-Chair, Working Committee, Infections and Immune Reconstitution Center for International Blood & Marrow Transplant Research
- Join now to see all
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Immune Reconstitution in Stem Cell Transplant Recipients Start of enrollment: 2012 Aug 15
Publications & Presentations
PubMed
- 3379 citationsAxicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaSattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos
The New England Journal of Medicine. 2017-12-10 - 1493 citationsChimeric antigen receptor T-cell therapy — assessment and management of toxicitiesSattva S. Neelapu, Sudhakar Tummala, Partow Kebriaei, William G. Wierda, Cristina Gutierrez
Nature Reviews. Clinical Oncology. 2018-01-01 - 1712 citationsASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector CellsDaniel W. Lee, Bianca Santomasso, Frederick L. Locke, Armin Ghobadi, Cameron J. Turtle
Biology of Blood and Marrow Transplantation. 2019-04-01
Abstracts/Posters
- Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lympho...Krishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- The Innate Immune Sensor Sting Promotes Donor CD8+ T Cell Activation and Recipient APC Death Early after Preclinical Allogeneic Hematopoietic Stem Cell TransplantationKrishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Multiple Pathways Targeting CD25 or TNFRSF25 Affect CD4+FoxP3+ Regulatory T Cell Phenotype and Suppressive FunctionKrishna V Komanduri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Renowned Hematology-Oncology Specialist to Lead UCSF Health’s Hematology-Oncology ProgramMarch 24th, 2022
Biomarker-Driven Cancer Care Is Not Reaching All AmericansSeptember 5th, 2020
Using Your Immune System to Fight Cancer Is Showing Significant PromiseMay 26th, 2017- Join now to see all
Grant Support
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2009–2011
- T Cell Reconstitution After Allogeneic SCTNational Cancer Institute2009
- Immune Reconstitution After Cord Blood TransplantationNational Heart, Lung, And Blood Institute2008
- T Cell Reconstitution After Allogeneic SCTNational Cancer Institute2005–2008
Committees
- Founding Member, ASBMT Education Committee 2010 - 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
